Concerns Surrounding Hangzhou Zhongtai Cryogenic Technology's (SZSE:300435) Performance
Concerns Surrounding Hangzhou Zhongtai Cryogenic Technology's (SZSE:300435) Performance
The recent earnings posted by Hangzhou Zhongtai Cryogenic Technology Corporation (SZSE:300435) were solid, but the stock didn't move as much as we expected. We think this is due to investors looking beyond the statutory profits and being concerned with what they see.
杭州中泰低溫科技股份有限公司(深交所股票代碼:300435)最近公佈的收益穩健,但該股的走勢沒有我們預期的那麼大。我們認爲這是由於投資者將目光投向了法定利潤之外並關注他們所看到的情況。
![earnings-and-revenue-history](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240423/0-992ae3427b405eb690d85769930b3ce7-0-ccfa3cbf300344008785835a3232a694.png/big)
The Impact Of Unusual Items On Profit
不尋常物品對利潤的影響
Importantly, our data indicates that Hangzhou Zhongtai Cryogenic Technology's profit received a boost of CN¥29m in unusual items, over the last year. We can't deny that higher profits generally leave us optimistic, but we'd prefer it if the profit were to be sustainable. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. Which is hardly surprising, given the name. Assuming those unusual items don't show up again in the current year, we'd thus expect profit to be weaker next year (in the absence of business growth, that is).
重要的是,我們的數據表明,去年,杭州中泰低溫科技的不尋常項目利潤增加了2900萬元人民幣。我們不能否認更高的利潤通常會讓我們感到樂觀,但如果利潤是可持續的,我們更願意這樣做。當我們分析全球絕大多數上市公司時,我們發現重大不尋常的事項往往不會重演。考慮到這個名字,這並不奇怪。假設這些不尋常的項目在本年度不會再次出現,因此我們預計明年的利潤將疲軟(也就是說,在業務沒有增長的情況下)。
That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.
這可能會讓你想知道分析師對未來盈利能力的預測。幸運的是,您可以單擊此處查看根據他們的估計描繪未來盈利能力的交互式圖表。
Our Take On Hangzhou Zhongtai Cryogenic Technology's Profit Performance
我們對杭州中泰低溫科技盈利表現的看法
We'd posit that Hangzhou Zhongtai Cryogenic Technology's statutory earnings aren't a clean read on ongoing productivity, due to the large unusual item. Because of this, we think that it may be that Hangzhou Zhongtai Cryogenic Technology's statutory profits are better than its underlying earnings power. But the good news is that its EPS growth over the last three years has been very impressive. The goal of this article has been to assess how well we can rely on the statutory earnings to reflect the company's potential, but there is plenty more to consider. Keep in mind, when it comes to analysing a stock it's worth noting the risks involved. Case in point: We've spotted 1 warning sign for Hangzhou Zhongtai Cryogenic Technology you should be aware of.
我們認爲,杭州中泰低溫科技的法定收益並不能完全反映持續的生產力,因爲這筆巨額不尋常。正因爲如此,我們認爲杭州中泰低溫科技的法定利潤可能好於其基礎盈利能力。但好消息是,其在過去三年中的每股收益增長非常令人印象深刻。本文的目標是評估我們在多大程度上可以依靠法定收益來反映公司的潛力,但還有很多需要考慮的地方。請記住,在分析股票時,值得注意所涉及的風險。一個很好的例子:我們已經發現了一個你應該注意的杭州中泰低溫科技的警告信號。
This note has only looked at a single factor that sheds light on the nature of Hangzhou Zhongtai Cryogenic Technology's profit. But there is always more to discover if you are capable of focussing your mind on minutiae. Some people consider a high return on equity to be a good sign of a quality business. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying.
這份報告只研究了揭示杭州中泰低溫科技利潤性質的單一因素。但是,如果你能夠將注意力集中在細節上,總會有更多的事情需要發現。有些人認爲高股本回報率是優質業務的好兆頭。因此,你可能希望看到這份免費收藏的擁有高股本回報率的公司,或者這份內部人士正在購買的股票清單。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。